These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33095822)

  • 1. Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index.
    Cheikhi AM; Johnson ZI; Julian DR; Wheeler S; Feghali-Bostwick C; Conley YP; Lyons-Weiler J; Yates CC
    PLoS One; 2020; 15(10):e0240986. PubMed ID: 33095822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.
    Mahoney JM; Taroni J; Martyanov V; Wood TA; Greene CS; Pioli PA; Hinchcliff ME; Whitfield ML
    PLoS Comput Biol; 2015 Jan; 11(1):e1004005. PubMed ID: 25569146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel classification for global gene signature model for predicting severity of systemic sclerosis.
    Johnson ZI; Jones JD; Mukherjee A; Ren D; Feghali-Bostwick C; Conley YP; Yates CC
    PLoS One; 2018; 13(6):e0199314. PubMed ID: 29924864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma -- news to tell.
    Eckes B; Hunzelmann N; Moinzadeh P; Krieg T
    Arch Dermatol Res; 2007 Jun; 299(3):139-44. PubMed ID: 17453220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.
    Dolcino M; Pelosi A; Fiore PF; Patuzzo G; Tinazzi E; Lunardi C; Puccetti A
    Front Immunol; 2018; 9():449. PubMed ID: 29559981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
    Affandi AJ; Carvalheiro T; Ottria A; Broen JC; Bossini-Castillo L; Tieland RG; Bon LV; Chouri E; Rossato M; Mertens JS; Garcia S; Pandit A; de Kroon LM; Christmann RB; Martin J; van Roon JA; Radstake TR; Marut W
    Ann Rheum Dis; 2019 Sep; 78(9):1249-1259. PubMed ID: 31126957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
    Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
    Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
    López-Isac E; Acosta-Herrera M; Kerick M; Assassi S; Satpathy AT; Granja J; Mumbach MR; Beretta L; Simeón CP; Carreira P; Ortego-Centeno N; Castellvi I; Bossini-Castillo L; Carmona FD; Orozco G; Hunzelmann N; Distler JHW; Franke A; Lunardi C; Moroncini G; Gabrielli A; de Vries-Bouwstra J; Wijmenga C; Koeleman BPC; Nordin A; Padyukov L; Hoffmann-Vold AM; Lie B; ; Proudman S; Stevens W; Nikpour M; ; Vyse T; Herrick AL; Worthington J; Denton CP; Allanore Y; Brown MA; Radstake TRDJ; Fonseca C; Chang HY; Mayes MD; Martin J
    Nat Commun; 2019 Oct; 10(1):4955. PubMed ID: 31672989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
    Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
    Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
    Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Dickkopf-1 in joint remodeling and fibrosis: A link connecting spondyloarthropathies and scleroderma?
    Klavdianou K; Liossis SN; Sakkas L; Daoussis D
    Semin Arthritis Rheum; 2017 Feb; 46(4):430-438. PubMed ID: 27670695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium.
    Gabrielsen A; Lawler PR; Yongzhong W; Steinbrüchel D; Blagoja D; Paulsson-Berne G; Kastrup J; Hansson GK
    J Mol Cell Cardiol; 2007 Apr; 42(4):870-83. PubMed ID: 17343875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts.
    Gardner H; Shearstone JR; Bandaru R; Crowell T; Lynes M; Trojanowska M; Pannu J; Smith E; Jablonska S; Blaszczyk M; Tan FK; Mayes MD
    Arthritis Rheum; 2006 Jun; 54(6):1961-73. PubMed ID: 16736506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis.
    Ikawa Y; Ng PS; Endo K; Kondo M; Chujo S; Ishida W; Shirasaki F; Fujimoto M; Takehara K
    J Cell Physiol; 2008 Sep; 216(3):680-7. PubMed ID: 18481257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
    Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
    Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
    Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
    Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.